glp 1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites Cited in 13 publications anti-GLP-1 Antibody [ABIN651691] - Human,
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
![glp 1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites Cited in 13 publications anti-GLP-1 Antibody [ABIN651691] - Human,](https://content.abcam.com/products/images/glp-1r-antibody-epr21819-ab218532--immunohistochemistry-frozen-sections-img34413.jpg)
![glp 1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites Cited in 13 publications anti-GLP-1 Antibody [ABIN651691] - Human,](https://www.researchgate.net/publication/377981370/figure/fig1/AS:11431281291619608@1732162478824/Conjugation-of-GLP-1-peptide-analog-to-GIPR-antibody-AMG-133-chemical-structure.jpg)
![glp 1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites Cited in 13 publications anti-GLP-1 Antibody [ABIN651691] - Human,](https://www.thermofisher.com/antibody/images/150/710320_WB.jpg?time=20220826)























